Immuneering Corporation Class A (IMRX) Dividend History
Immuneering Corporation Class A (IMRX) is a biotechnology company focused on developing therapies for complex neurological and oncology diseases. Founded with the goal of translating computational biology and data-driven insights into innovative treatments, Immuneering leverages its proprietary platform to identify and advance novel drug candidates. The company aims to accelerate drug discovery and improve patient outcomes through its expertise in genomics, computational models, and clinical development.
245 Main Street, Second Floor, Cambridge, MA, 02142
Phone: 617-500-8080
Website: https://www.immuneering.com
Phone: 617-500-8080
Website: https://www.immuneering.com
Dividend History
Immuneering Corporation Class A currently does not pay dividends
Company News
-
GlobeNewswire Inc.
-
GlobeNewswire Inc.
-
GlobeNewswire Inc.